Tactile Systems Technology (NASDAQ:TCMD) Announces Quarterly Earnings Results

Tactile Systems Technology (NASDAQ:TCMD) released its quarterly earnings results on Tuesday. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.09, Zacks reports. Tactile Systems Technology had a net margin of 5.79% and a return on equity of 9.56%. The business had revenue of $85.59 million for the quarter, compared to analyst estimates of $85.39 million. Tactile Systems Technology updated its FY 2025 guidance to EPS.

Tactile Systems Technology Trading Down 13.3 %

Tactile Systems Technology stock opened at $15.49 on Thursday. The stock has a 50-day moving average price of $17.38 and a 200 day moving average price of $15.65. The company has a market capitalization of $371.76 million, a price-to-earnings ratio of 22.13 and a beta of 1.20. Tactile Systems Technology has a 52 week low of $11.12 and a 52 week high of $21.10. The company has a quick ratio of 3.80, a current ratio of 4.37 and a debt-to-equity ratio of 0.12.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. B. Riley lowered Tactile Systems Technology from a “buy” rating to a “neutral” rating and reduced their target price for the company from $23.00 to $18.00 in a research report on Wednesday. Oppenheimer downgraded shares of Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a report on Tuesday, November 5th. StockNews.com cut shares of Tactile Systems Technology from a “strong-buy” rating to a “buy” rating in a research note on Thursday, January 16th. Finally, BTIG Research lowered shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating in a research note on Tuesday, November 5th.

Tactile Systems Technology Company Profile

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.